X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
cabazitaxel (573) 573
index medicus (333) 333
docetaxel (330) 330
humans (292) 292
prostate cancer (280) 280
male (263) 263
oncology (229) 229
chemotherapy (218) 218
enzalutamide (155) 155
abiraterone (147) 147
cancer (133) 133
abiraterone acetate (129) 129
mitoxantrone (121) 121
taxoids - therapeutic use (115) 115
metastasis (114) 114
prostatic neoplasms, castration-resistant - drug therapy (114) 114
castration-resistant prostate cancer (111) 111
urology & nephrology (103) 103
antineoplastic agents - therapeutic use (100) 100
prednisone (96) 96
taxoids - administration & dosage (93) 93
mitoxantrone plus prednisone (90) 90
pharmacology & pharmacy (89) 89
aged (88) 88
care and treatment (85) 85
increased survival (85) 85
survival (84) 84
prostatic neoplasms - drug therapy (80) 80
middle aged (77) 77
treatment outcome (76) 76
prostatic neoplasms, castration-resistant - pathology (75) 75
taxane (75) 75
sipuleucel-t (67) 67
medicine & public health (64) 64
taxoids - adverse effects (60) 60
antineoplastic combined chemotherapy protocols - therapeutic use (59) 59
paclitaxel (57) 57
antitumor-activity (56) 56
every 3 weeks (56) 56
men (56) 56
therapy (54) 54
trial (54) 54
neoplasm metastasis (52) 52
analysis (51) 51
prostatic neoplasms - pathology (51) 51
urology (49) 49
animals (48) 48
drug resistance, neoplasm (47) 47
drug therapy (47) 47
antineoplastic agents - administration & dosage (46) 46
double-blind (46) 46
castration (45) 45
research (45) 45
phenylthiohydantoin - analogs & derivatives (44) 44
taxoids - pharmacology (44) 44
metastatic castration-resistant prostate cancer (43) 43
aged, 80 and over (42) 42
androgen receptor (42) 42
prostate (42) 42
antineoplastic agents - pharmacology (39) 39
cell line, tumor (39) 39
antineoplastic agents - adverse effects (38) 38
hematology, oncology and palliative medicine (38) 38
antineoplastic agents (36) 36
disease progression (36) 36
taxanes (36) 36
antimitotic agents (35) 35
denosumab (35) 35
health aspects (34) 34
open-label (34) 34
plus prednisone (34) 34
tumors (34) 34
cancer therapies (33) 33
disease-free survival (33) 33
female (33) 33
adult (32) 32
development and progression (32) 32
radium-223 (31) 31
metastases (30) 30
phase-iii trial (30) 30
phenylthiohydantoin - therapeutic use (30) 30
prostatic neoplasms, castration-resistant - mortality (30) 30
immunotherapy (29) 29
patients (27) 27
prognosis (27) 27
prostate-specific antigen - blood (27) 27
toxicity (27) 27
urologic and male genital diseases (27) 27
article (26) 26
cancer research (26) 26
nanoparticles (26) 26
orchiectomy (26) 26
taxoids - chemistry (26) 26
taxoids - pharmacokinetics (26) 26
androgen antagonists - therapeutic use (25) 25
apoptosis (25) 25
clinical trials (25) 25
drugs (25) 25
pharmacokinetics (25) 25
retrospective studies (25) 25
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (506) 506
German (31) 31
French (19) 19
Russian (10) 10
Spanish (7) 7
Czech (4) 4
Portuguese (2) 2
Dutch (1) 1
Hungarian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of Clinical Oncology, ISSN 0732-183X, 02/2018, Volume 36, Issue 6_suppl, pp. 290 - 290
Journal Article
Clinical Cancer Research, ISSN 1078-0432, 03/2019, Volume 25, Issue 6, pp. 1880 - 1888
Patients with metastatic castration-resistant prostate cancer (mCRPC) have several treatment options; however, intrinsic and acquired resistance to various... 
mCRPC | cabazitaxel | ARv567es | AR-V7 | docetaxel
Journal Article
Molecular Cancer Therapeutics, ISSN 1535-7163, 06/2018, Volume 17, Issue 10, pp. molcanther.1269.2017 - 2205
Current treatments for castration resistant prostate cancer (CRPC) largely fall into two classes; AR-targeted therapies such as the next-generation... 
cabazitaxel | abiraterone | docetaxel | prostate cancer resistance | enzalutamide
Journal Article
Chemistry and Physics of Lipids, ISSN 0009-3084, 11/2019, Volume 224, p. 104707
Cabazitaxel as microtubule inhibitor and thymoquinone as HDAC inhibitor affects the important genes like p53, STAT3, Bax, BCL-2, p21 and down regulation of... 
Breast cancer | Synergistic combination | Lipospheres | Cabazitaxel | Thymoquinone
Journal Article
Onkourologiya, ISSN 1726-9776, 2018, Volume 14, Issue 2, pp. 130 - 141
Prostate cancer is one of the most common causes of death from oncological diseases in men. Taxanes (including docetaxel and cabazitaxel) are... 
Prostate cancer | Cabazitaxel | Docetaxel
Journal Article
Asian Journal of Pharmaceutical Sciences, ISSN 1818-0876, 2018
The potential side effects of cabazitaxel (CBZ) in the field of cancer treatment have become a great limitation to its further clinical application. Liposomal... 
Liposome | Stability | Biosafety | Cabazitaxel | Apoptosis
Journal Article
Gan to kagaku ryoho. Cancer & chemotherapy, ISSN 0385-0684, 06/2016, Volume 43, Issue 6, pp. 777 - 779
Journal Article
Molecular and Cellular Endocrinology, ISSN 0303-7207, 12/2019, Volume 498, p. 110585
Adrenocortical cancer (ACC) is a rare and aggressive malignancy with a poor prognosis. The overall 5-year survival rate of patients with ENS@T stage IV ACC is... 
Multi drug resistance | Adrenocortical carcinoma | Cabazitaxel | Apoptosis
Journal Article
European Urology, ISSN 0302-2838, 09/2018, Volume 74, Issue 3, pp. 292 - 293
Journal Article
Oncotarget, ISSN 1949-2553, 06/2019, Volume 10, Issue 41, p. 4161
Cabazitaxel is a second-generation taxane approved for use in patients with metastatic castration-resistant prostate cancer (mCRPC) previously treated with... 
Journal Article
Onkourologiâ, ISSN 1726-9776, 07/2018, Volume 14, Issue 2, pp. 130 - 141
Prostate cancer is one of the most common causes of death from oncological diseases in men. Taxanes (including docetaxel and cabazitaxel) are... 
docetaxel | cabazitaxel | prostate cancer
Journal Article
Lancet Oncology, ISSN 1470-2045, 2015, Volume 16, Issue 2, pp. 152 - 160
Journal Article
Cancer Chemotherapy and Pharmacology, ISSN 0344-5704, 02/2016, Volume 77, Issue 2, pp. 221 - 233
Journal Article
European Urology, ISSN 0302-2838, 2014, Volume 68, Issue 1, pp. 147 - 153
Journal Article
Lancet, The, ISSN 0140-6736, 2016, Volume 387, Issue 10024, pp. 1163 - 1177
Journal Article
European Urology, ISSN 0302-2838, 2011, Volume 60, Issue 2, pp. 279 - 290
Journal Article